Weiss Multi Strategy Advisers LLC Acadia Pharmaceuticals Inc Transaction History

Weiss Multi Strategy Advisers LLC

$0
Q1 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$13.01 - $27.22 $162,625 - $340,250	-12,500 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$20.94 - $27.5 $363,078 - $476,822	-17,339 Reduced 58.11%	12,500 $303,000
Q4 2021 Feb 14, 2022	SELL	$16.79 - $27.09 $644,131 - $1.04 Million	-38,364 Reduced 56.25%	29,839 $696,000
Q3 2021 Nov 15, 2021	BUY	$15.78 - $24.77 $12,513 - $19,642	793 Added 1.18%	68,203 $1.13 Million
Q2 2021 Aug 16, 2021	SELL	$19.4 - $27.42 $632,246 - $893,617	-32,590 Reduced 32.59%	67,410 $1.64 Million
Q1 2021 May 14, 2021	SELL	$25.02 - $54.99 $793,984 - $1.75 Million	-31,734 Reduced 24.09%	100,000 $2.58 Million
Q4 2020 Feb 16, 2021	BUY	$41.04 - $56.79 $17,852 - $24,703	435 Added 0.33%	131,734 $7.04 Million
Q3 2020 Nov 16, 2020	BUY	$36.42 - $57.0 $1.25 Million - $1.96 Million	34,299 Added 35.36%	131,299 $5.42 Million
Q2 2020 Aug 14, 2020	BUY	$39.26 - $52.73 $63,365 - $85,106	1,614 Added 1.69%	97,000 $4.7 Million
Q1 2020 May 15, 2020	BUY	$31.65 - $46.87 $12,216 - $18,091	386 Added 0.41%	95,386 $4.03 Million
Q4 2019 Feb 14, 2020	BUY	$36.21 - $51.4 $289,680 - $411,200	8,000 Added 9.2%	95,000 $4.06 Million
Q3 2019 Nov 14, 2019	SELL	$22.22 - $44.01 $555,500 - $1.1 Million	-25,000 Reduced 22.32%	87,000 $3.13 Million
Q1 2019 May 15, 2019	BUY	$16.17 - $27.38 $32,340 - $54,760	2,000 Added 1.82%	112,000 $3.01 Million
Q4 2018 Feb 14, 2019	SELL	$14.32 - $22.92 $429,600 - $687,600	-30,000 Reduced 21.43%	110,000 $1.78 Million
Q3 2018 Nov 14, 2018	BUY	$13.03 - $21.81 $130,300 - $218,100	10,000 Added 7.69%	140,000 $2.91 Million
Q2 2018 Aug 14, 2018	BUY	$15.07 - $22.34 $753,500 - $1.12 Million	50,000 Added 62.5%	130,000 $1.99 Million
Q1 2018 May 15, 2018	BUY	$22.47 - $32.33 $954,975 - $1.37 Million	42,500 Added 113.33%	80,000 $1.8 Million
Q4 2017 Feb 14, 2018	BUY	$26.84 - $39.14 $335,500 - $489,250	12,500 Added 50.0%	37,500 $1.13 Million
Q3 2017 Nov 14, 2017	BUY	$29.49 - $38.37 $737,250 - $959,249	25,000	25,000 $942,000

Others Institutions Holding ACAD

# of Institutions

279

Shares Held

156M

Call Options Held

901K

Put Options Held

314K

View Full List

About ACADIA PHARMACEUTICALS INC

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $2.73B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

More about ACAD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Weiss Multi Strategy Advisers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Weiss Multi Strategy Advisers LLC with notifications on news.

Account